GLP-1 Hair Loss: Why It Happens, How Long It Lasts and What Actually Helps

The Bag Blogs · Wellness Education · From the Clinicians

Written by Nadine Gonzalez, MS, PA-C · Founder of Bag Bar | Red Bank, NJ | November 2026 | 11 min read

The Short Answer

Yes, hair shedding can happen on a GLP-1 medication, and it is listed in the FDA prescribing information for both Zepbound (tirzepatide) and Wegovy (semaglutide). In the Zepbound weight-loss trials, 4 to 5 percent of people on the drug reported hair loss versus 1 percent on placebo. In the Wegovy trials it was 3 percent versus 1 percent. Most people did not report it.

For most people it appears to be telogen effluvium, a temporary kind of shedding that dermatologists link to rapid weight loss, and the hair usually grows back over several months. Some studies also link GLP-1s to more male or female pattern hair loss (androgenetic alopecia), and researchers do not yet know whether the drugs cause it or simply uncover it in people already prone to it. The data come from the brand-name drugs; we found no studies on hair loss with compounded semaglutide or tirzepatide specifically. It could possibly be aggravated by GLP-1s, but like most of the side effects associated with these medications, hair shedding is also seen in people who lose weight rapidly for any reason, whether or not they use a GLP-1. The practical takeaway: it is common enough to plan for and usually not permanent. Do not stop your medication on your own.

Book your Metabolic Reset consult

Hair shedding on a GLP-1 is common enough to plan for, usually temporary, and never something to figure out alone.

If you have started semaglutide or tirzepatide, or you are thinking about it, you have probably seen the posts: "I am losing weight and my hair is coming out in the shower." Some of those posts are dramatic and many come from companies selling a supplement. We want you to have the calm, evidence-based version, including the parts that are still uncertain.

How common is hair loss on a GLP-1?

Here is what the evidence says, starting with the most reliable sources.

• Zepbound (tirzepatide) FDA label, revised February 2026: In the pooled placebo-controlled weight-loss trials, hair loss was reported by 5 percent of people on the 5 mg dose, 4 percent on 10 mg and 5 percent on 15 mg, versus 1 percent on placebo. Among women it was 7.1 percent versus 1.3 percent on placebo. Among men it was 0.5 percent versus none. The label says the hair loss was associated with weight reduction, and no one on Zepbound stopped treatment because of it in those trials.
• Wegovy (semaglutide) FDA label, revised May 2026: Hair loss was reported by 3 percent of people taking semaglutide 2.4 mg weekly versus 1 percent on placebo.
• A 2026 systematic review (Gupta and colleagues, Science Progress) examined 24 studies. It found tirzepatide was the medication most often linked to telogen effluvium, that hair loss on semaglutide appeared to be dose-dependent with doses under 2 mg weekly rarely implicated, and that women appeared to be affected more often. One large U.S. database analysis summarized in the review found tirzepatide users had a higher rate of telogen effluvium than people on other weight-loss medications (hazard ratio 2.65), with no increase seen for semaglutide or liraglutide in that analysis.

Put simply: most people in the trials did not report hair loss, but it was reported several times more often than with placebo, and women in the tirzepatide trials reported it more.

Why does hair fall out on a GLP-1?

Your hair grows in cycles. At any time, most of your hairs are growing and a smaller share are resting. In telogen effluvium, a physical stressor pushes more hairs than usual into the resting phase, and a few months later they shed. The American Academy of Dermatology lists losing 20 pounds or more among the triggers, along with childbirth, high fever, surgery and major stress.

• Rapid weight loss is the leading explanation. The Zepbound label ties the hair loss to weight reduction, and the 2026 review names rapid weight loss as a potential contributor.
• Nutrition can add to it. StatPearls lists crash dieting, low protein intake and iron deficiency as triggers. GLP-1 medications lower appetite, so it is easy to under-eat protein, iron, zinc and other nutrients without noticing.
• Existing hair thinning can show up. A shedding episode can make male or female pattern thinning more noticeable in people already prone to it. More on that below.
• The medication itself is not ruled out. Whether GLP-1 drugs affect hair beyond the weight loss they cause is not settled.

When does it start and how long does it last?

StatPearls describes the trigger as typically happening about three months before shedding begins, within a range of one to six months. In practice, that means shedding often shows up a few months into treatment, not in the first weeks, and it can be surprising because you may feel fine by then.

Acute telogen effluvium is temporary. StatPearls notes that regrowth can take up to six months to start and longer to look noticeable, and the American Academy of Dermatology says hair usually regains its normal fullness within six to nine months. If the trigger keeps going, such as ongoing rapid weight loss or low nutrient intake, shedding can last longer.

Does it also trigger male or female pattern hair loss?

Telogen effluvium is the most common explanation, but it is not the whole story. Several 2026 studies point to an increase in androgenetic alopecia (the genetic, progressive thinning known as male or female pattern hair loss) as well.

• A 2026 meta-analysis (Viquez Burboa and colleagues, Skin Appendage Disorders) pooled 17 studies. At 12 months it found higher odds of androgenetic alopecia (adjusted odds ratio 1.64, 95% confidence interval 1.35 to 1.99) and of telogen effluvium (1.76, 1.34 to 2.32). Alopecia areata was not significantly increased. The authors point mainly to micronutrient deficiency from weight loss as the mechanism.
• A genetic study in the Journal of Investigative Dermatology (NYU Grossman, 2026) used variants in the GLP-1 receptor gene as a proxy for GLP-1 activity and reported about 7 percent added risk of male-pattern hair loss, as described by the Dermatology Digest. The populations were mostly White and mostly men, the biological mechanism is unknown, and it is not known whether the finding applies to women.
• A 2026 narrative review (Seyed Jafari and colleagues, American Journal of Clinical Dermatology) describes a 283-patient study in which 12.4 percent had hair loss, with male or female pattern hair loss (7.7 percent) more common than telogen effluvium (4.1 percent). The reviewers argue that telogen effluvium from rapid weight loss or metabolic stress is more likely than a direct effect on hair follicles.

What this means in plain English: a GLP-1 may unmask male or female pattern thinning in someone who was already genetically prone to it, or it may add to it. Shedding from telogen effluvium tends to settle once weight stabilizes. Male and female pattern hair loss do not. If thinning at the part line, crown or temples keeps progressing after your weight steadies, that is a reason to see a dermatologist, because treatment works better when it starts early.

What about compounded semaglutide and tirzepatide?

This is the question we get from our own clients, because Bag Bar prescribes compounded GLP-1 medications. Here is where the evidence stands.

• The hair loss numbers come from brand-name products. The Zepbound and Wegovy labels report trials of those FDA-approved drugs. The systematic review, meta-analysis and database studies above are about GLP-1 users in general, and the ones we could read do not separate compounded from brand products.
• We could not find any study comparing hair loss between compounded and FDA-approved semaglutide or tirzepatide. We do not know whether the rate is higher, lower or the same.
• It is reasonable to expect similar patterns, but that is an assumption. Since shedding appears tied mainly to how much and how fast weight comes off, and to nutrition, the same principles likely apply regardless of product. That is not proven.
• Compounded drugs are not FDA-approved. A 2025 review in the American Journal of Managed Care describes quality and dosing concerns with compounded semaglutide, including patient dosing errors with unlabeled vials. The review had few studies to draw on and contains no hair loss data. Accurate dosing matters for hair too, since an overshoot can speed up weight loss.

This is why we use a licensed pharmacy, start low, and show every patient how to draw up and inject their dose during the home visit. If you use a compounded product from any source, ask exactly what concentration is on the label and how many units equal your dose, and bring your questions to your prescribing clinician.

The other side: what we do not know

If the evidence has a catch, you should hear about it. Here are the catches.

• Cause and effect is not proven. Much of the research is observational, and the authors of the 2026 review call for large randomized trials. The obesity trials were not designed to study hair.
• Some of this is the weight loss, not the drug. Any large, fast weight loss can trigger shedding, whether from a crash diet, surgery or a medication.
• Most data are from brand-name drugs. We found no hair loss study that looks at compounded products specifically.
• The numbers differ by study. The labels report single-digit percentages, while surveys and database studies vary widely with who is counted and how.
• The supplement market has run ahead of the science. Many online pages promise to "stop GLP-1 hair loss." We could not find a trial showing that any supplement prevents it.

What can help (and what we cannot promise)

• Avoid losing weight faster than you need to. It is not proven that a slower pace prevents shedding, but since rapid loss is the leading explanation, it is a reasonable goal and a core part of our lowest-effective-dose approach. Read how we think about dosing.
• Eat enough. Ask your clinician or a registered dietitian how much protein and how many calories are right for you. Skipping meals because you are not hungry can backfire for your hair.
• Look for fixable causes. For shedding, StatPearls says a history and exam are usually enough, with iron studies when iron deficiency is suspected and a thyroid test when symptoms point that way. It notes that ferritin alone can look normal despite iron deficiency, and that correcting low iron, zinc or vitamin D allows regrowth. Your clinician decides which labs make sense for you.
• More is not always better. StatPearls lists excess vitamin A among the triggers of telogen effluvium, so piling on supplements can backfire.
• See a dermatologist when needed. Go if shedding is heavy, patchy, painful or itchy, or lasts past about six months. The American Academy of Dermatology says a dermatologist can tell shedding from other types of hair loss and find the cause.
• Do not stop your medication on your own. The American Academy of Dermatology advises talking with a doctor before stopping a drug that may be causing hair loss. Your clinician can adjust the plan.

Where does biotin fit in?

Biotin is the supplement everyone mentions for hair, so it deserves a straight answer. Here is what the evidence supports.

First, the theory. Biotin (vitamin B7) is a helper molecule, a cofactor, for five enzymes called carboxylases that handle fat, sugar and amino acid metabolism, according to the NIH. Hair is made mostly of a protein called keratin, and hair follicles are among the most active tissues in the body. It is a reasonable idea that a cell-heavy tissue like a hair follicle needs these metabolic building blocks to make strong, well-formed hair, and that is the basis for the hair, skin and nail claims. The 2017 review in Skin Appendage Disorders says biotin's role in protein and keratin production is why it is thought to contribute to hair and nail growth, but it does not show the mechanism, and it cites laboratory work finding that normal follicle cells do not grow faster when given biotin. In short, the theory is plausible, not demonstrated.

The theory gets its credibility from deficiency. When biotin is truly low, thinning hair, brittle nails and a scaly rash can result, according to the NIH. What is not shown in controlled research is that extra biotin improves the strength or condition of healthy hair.

The anecdotes are abundant. Reports of better hair quality with biotin supplementation are everywhere, and we do not dismiss them. Many people say their hair feels stronger, looks healthier or breaks less. Personal experience is still not the same as controlled evidence, because hair changes on its own over time, other habits often change at the same moment, and expectation can color what we notice. That is why the studies matter, and why we describe biotin as plausible and popular, not proven.

• The NIH Office of Dietary Supplements says the hair claims for biotin are supported, at best, by a few case reports and small studies. True deficiency is rare in healthy people eating a mixed diet, and the adequate intake for adults is 30 micrograms a day.
• Two reviews of the research reached similar conclusions. A 2017 review (Patel and colleagues) found biotin helped in cases of true deficiency and in rare conditions such as uncombable hair syndrome, but there was not enough evidence to recommend it for healthy people. A 2024 review (Yelich and colleagues) found no studies showing biotin improves hair growth in healthy individuals.
• For GLP-1 shedding specifically, we could not find a trial testing biotin. Anyone who promises it will stop your shedding is promising more than the research can back up.

So is there a role for the vitamins in your bag? Our Beauty Bag IV contains vitamin C, B-complex, B12, glutathione and biotin. Many clients on a GLP-1 ask about it, and here is how we frame it. Eating less can make it harder to take in a full range of vitamins from food, and some people enjoy the Beauty Bag as part of their wellness routine. It is not a treatment for hair loss, and we will not promise regrowth.

One safety note about biotin and blood tests. The FDA and NIH both warn that biotin can distort some lab results, including thyroid tests and troponin, sometimes without anyone noticing. A 2024 review suggests holding biotin at least two days before a blood draw, and longer for high doses. If you take biotin by mouth or have had it by IV, tell your clinician and plan the timing of your labs together.

See the Bag Bar menu

How Bag Bar approaches GLP-1 care in Monmouth County, NJ

• Lowest effective dose. We start low, increase gradually and aim for the smallest dose that gets you to your goal, which also helps avoid unnecessarily rapid weight loss.
• Labs and follow-up. Your licensed clinician orders your labs, reviews the results with you and checks in as you go, so questions like "is my hair loss normal?" get answered early.
• We come to you. If you qualify for medication and move forward, we visit your home for a focused physical exam and vitals, plus a hands-on injection demonstration.

The consult is $199. It includes a consult with a licensed clinician, who orders your labs and reviews the results with you. Lab fees are billed separately by Labcorp or Quest through your insurance.

Book your Metabolic Reset consult

GLP-1 Hair Loss FAQ

Can GLP-1 medications like semaglutide and tirzepatide cause hair loss?

Yes, hair shedding is a recognized side effect. It is listed in the FDA prescribing information for both Zepbound (tirzepatide) and Wegovy (semaglutide), and the Zepbound label says the hair loss was associated with weight reduction. For most people it appears to be telogen effluvium, a temporary form of shedding linked to rapid weight loss. Research is still mostly observational, so the exact role of the medications themselves is not settled.

How common is hair loss on a GLP-1?

In the pooled Zepbound weight-loss trials, hair loss was reported by 4 to 5 percent of people taking tirzepatide versus 1 percent on placebo, and by 7.1 percent of women versus 1.3 percent on placebo. In the Wegovy trials it was 3 percent on semaglutide 2.4 mg versus 1 percent on placebo. Most people in these trials did not report hair loss. Some real-world studies suggest tirzepatide is linked to shedding more often than semaglutide.

Why does hair shed on a GLP-1?

The leading explanation is telogen effluvium. A body stressor, such as losing a lot of weight quickly, pushes more hairs than usual into the resting phase, and they shed a few months later. Low intake of protein, calories, iron, zinc or vitamin D can add to it, and GLP-1 medications reduce appetite, which can make under-eating easy. Whether the medications affect hair beyond the weight loss they cause is not settled.

Do GLP-1 medications cause male or female pattern hair loss (androgenetic alopecia) too?

Studies suggest an association, but cause and effect are not proven. A 2026 meta-analysis of 17 studies found higher odds of androgenetic alopecia (adjusted odds ratio 1.64) and of telogen effluvium (1.76) at 12 months, while alopecia areata was not significantly increased. A shedding episode can also make existing male or female pattern thinning more noticeable in people already prone to it. If thinning at the part, crown or temples keeps progressing, see a dermatologist, because male and female pattern hair loss do not usually resolve on their own.

Is hair loss different with compounded semaglutide or tirzepatide?

We do not know. The FDA label figures come from trials of the brand-name products, and we could not find any study comparing hair loss between compounded and FDA-approved semaglutide or tirzepatide. Because shedding appears tied mainly to how much and how fast weight comes off, similar patterns are plausible but unproven. Compounded drugs are not FDA-approved, and published reviews describe dosing errors with vials that were not clearly labeled, so accurate dosing and a licensed pharmacy matter.

When does GLP-1 hair loss start, and how long does it last?

Telogen effluvium typically starts about three months after the trigger, within a range of one to six months, so shedding often appears a few months into treatment rather than in the first weeks. Dermatology sources describe it as temporary. The American Academy of Dermatology says hair usually regains its normal fullness within six to nine months, although shedding can last longer if the trigger, such as ongoing rapid weight loss or poor nutrition, continues.

What can I do to reduce hair loss on a GLP-1?

Nothing is proven to prevent it, but sensible steps include avoiding unnecessarily fast weight loss, eating enough protein and calories, and asking your clinician about checking for fixable causes such as iron deficiency, thyroid problems and low vitamin D or zinc. Remember that more is not always better with supplements, since excess vitamin A can itself trigger shedding. Do not stop or change your medication on your own. Talk with your prescribing clinician first.

Does biotin help GLP-1 hair loss?

There is no good evidence that it does. The NIH Office of Dietary Supplements says the hair benefits of biotin are supported, at best, by a few case reports and small studies, and that true deficiency is rare in healthy people eating a mixed diet. Published reviews found no studies showing biotin helps hair growth in healthy people, and we could not find a trial testing it for GLP-1 related shedding. Anecdotal reports of better hair quality with biotin are abundant, but personal experience is not the same as controlled evidence.

Can biotin interfere with my blood tests?

Yes. The FDA and NIH both warn that biotin in supplements can distort certain lab results, including thyroid tests and troponin, sometimes in ways that go unnoticed. One review suggests stopping biotin at least two days before a blood draw, and longer for high doses. Tell your clinician and the lab about any biotin you take by mouth or IV, and plan the timing of labs with your clinician.

Should I stop my GLP-1 if my hair is falling out?

Not on your own. For most people shedding is temporary, and whether the benefits of the medication outweigh a side effect like this is a decision to make with your prescribing clinician. The American Academy of Dermatology advises talking with a doctor before stopping a medication that may be causing hair loss. Your clinician may adjust how fast the dose increases, check your nutrition and labs, or refer you to a dermatologist.

When should I see a dermatologist about hair loss on a GLP-1?

See one if shedding is heavy, if you notice bald patches, scalp redness, itching or pain, if it lasts beyond about six months, or if it worries you. A dermatologist can tell shedding apart from other types of hair loss and find the cause. The American Academy of Dermatology notes that for true hair loss, starting treatment sooner gives a better outlook.

Does Bag Bar offer GLP-1 care and vitamin bags in Red Bank and Monmouth County, NJ?

Yes. Bag Bar's Metabolic Reset program offers compounded semaglutide and tirzepatide through a licensed PA-C under physician medical director oversight, built around the lowest effective dose, with house-call convenience across Monmouth County. The $199 consult includes a consult with a licensed clinician, who orders your labs and reviews the results with you. Lab fees are billed separately by Labcorp or Quest through your insurance. Our Beauty Bag IV contains vitamin C, B-complex, B12, glutathione and biotin. Book at bagbariv.com/reservations.

About the author: Nadine, MS, PA-C, is the founder and CEO of Bag Bar, a mobile concierge IV therapy and wellness company based in Red Bank, NJ, co-owned with its physician medical director and operating under that physician's supervision.

This article is for educational purposes only and is not medical advice. Talk with a licensed healthcare provider before starting, changing or stopping any prescription medication or supplement. Individual results vary. IV vitamin therapy is a wellness service and is not a treatment for hair loss or any disease. Compounded medications are not FDA-approved. Information is current as of November 13, 2026.

Sources: U.S. FDA, ZEPBOUND (tirzepatide) prescribing information, revised 02/2026, Section 6.1 (FDA label) · U.S. FDA, WEGOVY (semaglutide) prescribing information, revised 05/2026, Section 6.1 (FDA label) · Gupta AK, Teasell EM, Economopoulos V, Mirmirani P. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Science Progress, 2026 (PMC) · American Academy of Dermatology, Do you have hair loss or hair shedding? (read it) · Hughes EC, Syed HA, Saleh D. Telogen Effluvium. StatPearls, updated May 2024 (NCBI Bookshelf) · Viquez Burboa GU, Flores Guillen MAR, Duardo Gonzalez VS. GLP-1 receptor agonists and alopecia: a systematic review and meta-analysis of incidence, risk, subtypes, and mechanisms. Skin Appendage Disorders, 2026 (PubMed) · Seyed Jafari SM, Caro G, Lipner SR, Iorizzo M. The impact of GLP-1 receptor agonists on hair: beneficial effects or adverse outcomes? American Journal of Clinical Dermatology, 2026;27(3):579-586 (PMC) · The Dermatology Digest, Study uncovers first genetic link between GLP-1RA use and male-pattern hair loss, reporting on a 2026 Journal of Investigative Dermatology study (read it) · Gupta AK, et al. Alopecia signals with semaglutide and tirzepatide in the FDA Adverse Event Reporting System, J Cosmet Dermatol, 2026, as reported by Dermatology Times (read it) · Liu et al. Navigating compounded semaglutide: what health care providers need to know. American Journal of Managed Care, 2025;31(9):480-484 (read it) · Lal K. Your patient is on a GLP-1: a dermatologist's guide to what comes next. Dermatology Times, April 2026 (read it) · NIH Office of Dietary Supplements, Biotin fact sheet for health professionals (read it) · Yelich A, Jenkins H, Holt S, Miller R. Biotin for hair loss: teasing out the evidence. J Clin Aesthet Dermatol, 2024;17(8):56-61 (PMC) · Patel DP, Swink SM, Castelo-Soccio L. A review of the use of biotin for hair loss. Skin Appendage Disorders, 2017;3(3):166-169 (PMC) · U.S. FDA, Biotin interference with troponin lab tests (read it)